Skip to main content
TipRanks
Go Ultimate75% OFF

Indo Amines Limited (INDOAMIN) AI Stock Analysis

2 Followers
IN:INDOAMIN

Indo Amines Limited

(NSE:INDOAMIN)

Select Model
Rating:78Outperform
Price Target:INR 129.00▲(13.71% Upside)
Action:reiterated
Date:10/07/26

Strong financial performance from revenue expansion and balance sheet gains is the main driver, reinforced by bullish technical momentum above moving averages.

Positive Factors
Revenue GrowthSteady revenue expansion indicates continuing demand for the company’s amines and chemical intermediates across its industrial customer base. The FY2026 acceleration provides a stronger near-term foundation for operating leverage, reinvestment, and sustained participation in served end markets.
Negative Factors
Negative Free Cash FlowRepeatedly negative free cash flow shows that recent accounting earnings have not consistently converted into surplus cash after investment needs. This can increase reliance on financing or working-capital improvement, limiting flexibility to fund expansion and absorb operating setbacks.

Indo Amines Limited (INDOAMIN) vs. iShares MSCI India ETF (INDA)

-40%-30%-20%-10%0%10%20%30%40%IN:INDOAMIN-6.44%INDA-4.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 10.39B
Dividend Yield
0.44%
Average Volume (3M)
24.97K
Price to Earnings (P/E)
10.2
Beta (1Y)
1.44
Revenue Growth
22.17%
EPS Growth
1.86%
Country
India
Employees
619
Sector
General
Sector Strength
55
Industry
Chemicals

Indo Amines Limited Business Overview & Revenue Model

Company Description

Indo Amines Limited operates as a global manufacturer and supplier, focusing on the development and production of a comprehensive range of chemicals, including fine, specialty, performance, and perfumery chemicals, alongside active pharmaceutical ing...

How the Company Makes Money

Indo Amines Limited makes money mainly by manufacturing and selling amines and amine-based specialty/intermediate chemicals to other businesses. Revenue is generated through (1) sale of manufactured chemical products: the company produces amines and...

Indo Amines Limited Financial Statement Overview

Summary

Robust revenue growth from 5.3B to 11.6B and improving net margins to 6.8% supported by balance sheet stability and lower leverage, offset by volatile free cash flow from high capex.

Income Statement

85Very Positive

Balance Sheet

82Very Positive

Cash Flow

65Positive
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue12.47B11.60B10.79B9.40B9.41B7.79B
Gross Profit3.37B3.04B2.75B2.20B2.30B1.91B
EBITDA1.57B1.23B1.16B936.55M913.41M604.51M
Net Income812.40M793.26M558.95M428.13M408.75M230.47M
Balance Sheet
Total Assets08.97B7.79B6.33B5.97B5.54B
Cash, Cash Equivalents and Short-Term Investments237.05M237.05M167.79M55.89M60.73M61.66M
Total Debt03.11B2.84B2.17B2.32B2.07B
Total Liabilities-3.94B5.04B4.61B3.70B3.71B3.67B
Stockholders Equity3.94B3.92B3.17B2.63B2.25B1.87B
Cash Flow
Free Cash Flow-81.70M-220.64M-216.82M391.02M-109.75M-242.71M
Operating Cash Flow363.28M563.71M697.01M696.71M203.63M154.59M
Investing Cash Flow-375.71M-718.75M-904.58M-265.64M-298.27M-388.40M
Financing Cash Flow66.32M225.81M153.96M-408.70M40.26M319.15M

Indo Amines Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price113.45

Price Trends

50DMA131.62Negative
100DMA129.08Negative
200DMA121.84Negative

Market Momentum

MACD-5.79Positive
RSI36.00Neutral
STOCH7.81Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:INDOAMIN, the sentiment is Negative. The current price of 113.45 is below the 20-day moving average (MA) of 120.99, below the 50-day MA of 131.62, and below the 200-day MA of 121.84, indicating a bearish trend. The MACD of -5.79 indicates Positive momentum. The RSI at 36.00 is Neutral, neither overbought nor oversold. The STOCH value of 7.81 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:INDOAMIN.

Indo Amines Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:INDOAMIN against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:INDOAMININ:INDOAMIN78OutperformINR 8.24B10.15―0.44%22.17%1.86%
IN:AMNPLSTIN:AMNPLST66NeutralINR 8.47B20.26―0.33%-5.09%12.63%
IN:INDIAGLYCOIN:INDIAGLYCO64NeutralINR 18.09B5.47―0.96%12.01%23.71%
IN:VALIANTORGIN:VALIANTORG63NeutralINR 9.50B14.50――21.32%175.87%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:PRIMOIN:PRIMO54NeutralINR 4.84B30.57――-2.70%-15.41%
IN:DMCCIN:DMCC53NeutralINR 6.38B16.94―0.97%72.14%34.49%

* General Sector Average

Performance Comparison

-25%0%25%50%75%IN:INDOAMININ:AMNPLSTIN:DMCCIN:INDIAGLYCOIN:PRIMOIN:VALIANTORGDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:INDOAMIN and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:INDOAMINIndo Amines Limited113.45-12.09-9.63%
IN:AMNPLSTAmines & Plasticizers Ltd.154.00-41.41-21.19%
IN:DMCCDMCC Speciality Chemicals Limited255.65-5.90-2.26%
IN:INDIAGLYCOIndia Glycols Limited269.9539.3317.05%
IN:PRIMOPrimo Chemicals Limited19.99-2.27-10.20%
IN:VALIANTORGValiant Organics Limited338.8070.1026.09%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 06, 2026